Top

Published in:

09-08-2023 | Rosacea | REVIEW

Rosacea in children: a review

Authors: Anca Chiriac, Uwe Wollina

Published in: European Journal of Pediatrics | Issue 10/2023

Abstract

Rosacea is a facial inflammatory disorder that shows an increasing incidence with age. While rosacea is common > 60 years of age, pediatric rosacea is uncommon. Diagnostic criteria are based on clinical symptoms. Laboratory investigations and histopathology are only needed to exclude other differential diagnoses. There are several subtypes such as erythemato-telangiectatic, papulo-pustular, periorificial, and granulomatous variants. In contrast to adult rosacea, phymatous subtypes do not belong to pediatric rosacea. A special subtype seen in infants and children is an idiopathic facial aseptic granuloma. Genetic and environmental factors contribute to its pathogenesis. Treatment options are in analogy to adult rosacea classified into topical and systemic drugs. In the case of oral tetracyclines, discoloration of teeth and impairment of enamel are possible adverse events.

Conclusion: Pediatric rosacea belongs to the rosacea spectrum but has peculiarities compared to the adult subtype.

What is Known: • Rosacea is a chronic inflammatory disorder different from acne. • Rosacea gets more common with advanced age.
What is New: • Pediatric rosacea is an uncommon subtype with peculiar clinical presentation. • Demodicosis is very rare in immunocompetent children.

van Zuuren EJ, Arents BWM, van der Linden MMD, Vermeulen S, Fedorowicz Z, Tan J (2021) Rosacea: new concepts in classification and treatment. Am J Clin Dermatol 22(4):457–465. https://doi.org/10.1007/s40257-021-00595-7CrossRefPubMedPubMedCentral

Goel NS, Burkhart CN, Morrell DS (2015) Pediatric periorificial dermatitis: clinical course and treatment outcomes in 222 patients. Pediatr Dermatol 32(3):333–336. https://doi.org/10.1111/pde.12534CrossRefPubMed

Nguyen V, Eichenfield LF (2006) Periorificial dermatitis in children and adolescents. J Am Acad Dermatol 55(5):781–785. https://doi.org/10.1016/j.jaad.2006.05.031CrossRefPubMed

Boralevi F, Léauté-Labrèze C, Lepreux S, Barbarot S, Mazereeuw-Hautier J, Eschard C, Taïeb A; Groupe de Recherche Clinique en Dermatologie Pédiatrique (2007) Idiopathic facial aseptic granuloma: a multicentre prospective study of 30 cases. Br J Dermatol 156(4):705–708. https://doi.org/10.1111/j.1365-2133.2006.07741.xCrossRef

Chamaillard M, Mortemousque B, Boralevi F, Marques da Costa C, Aitali F, Taïeb A, Léauté-Labrèze C (2008) Cutaneous and ocular signs of childhood rosacea. Arch Dermatol 144(2):167–171. https://doi.org/10.1001/archdermatol.2007.50CrossRefPubMed

Zitelli KB, Sheil AT, Fleck R, Schwentker A, Lucky AW (2015) Idiopathic facial aseptic granuloma: review of an evolving clinical entity. Pediatr Dermatol 32(4):e136–e139. https://doi.org/10.1111/pde.12571CrossRefPubMed

Léauté-Labrèze C, Chamaillard M (2007) Paediatric rosacea. Ann Dermatol Venereol 134(10 Pt 1):788–792. https://doi.org/10.1016/s0151-9638(07)92543-0CrossRefPubMed

Patrizi A, Neri I, Chieregato C, Misciali M (1997) Demodecidiosis in immunocompetent young children: report of eight cases. Dermatology 195:239–242. https://doi.org/10.1159/000245951CrossRefPubMed

Douglas A, Zaenglein AL (2019) A case series of demodicosis in children. Pediatr Dermatol 36(5):651–654. https://doi.org/10.1111/pde.13852CrossRefPubMed

10.

Noguera-Morel L, Hernández-Martín A, Torrelo A (2021) Childhood rosacea and related disorders. Clin Exp Dermatol 46(3):430–443. https://doi.org/10.1111/ced.14419CrossRefPubMed

11.

Nazir SA, Murphy S, Siatkowski RM, Chodosh J, Siatkowski RL (2004) Ocular rosacea in childhood. Am J Ophthalmol 137:138–144. https://doi.org/10.1016/s0002-9394(03)00890-0CrossRefPubMed

12.

Knöpfel N, Gómez-Zubiaur A, Noguera-Morel L, Torrelo A, Hernandez-Martin A (2018) Ultrasound findings in idiopathic facial aseptic granuloma: case series and literature review. Pediatr Dermatol 35(3):397–400. https://doi.org/10.1111/pde.13324CrossRefPubMed

13.

Neri I, Raone B, Dondi A, Misciali C, Patrizi A (2013) Should idiopathic facial aseptic granuloma be considered granulomatous rosacea? Report of three pediatric cases. Pediatr Dermatol 30(1):109–111. https://doi.org/10.1111/j.1525-1470.2011.01689.xCrossRefPubMed

14.

Salerni G, Peralta R, Bertaina C, Gorosito M, Fernández-Bussy R (2020) Dermoscopy of idiopathic facial aseptic granuloma. Clin Exp Dermatol 45(5):605–606. https://doi.org/10.1111/ced.14174CrossRefPubMed

15.

Crawford GH, Pelle M, James WD (2004) Rosacea: I. Etiology, pathogenesis, and subtype classification. J Am Acad Dermatol 51:327–341. https://doi.org/10.1016/j.jaad.2004.03.030CrossRefPubMed

16.

Aldrich N, Gerstenblith M, Fu P, Tuttle MS, Varma P, Gotow E, Cooper KD, Mann M, Popkin DL (2015) Genetic vs environmental factors that correlate with rosacea: a cohort-based survey of twins. JAMA Dermatol 151(11):1213–1219. https://doi.org/10.1001/jamadermatol.2015.2230CrossRefPubMed

17.

Zhu W, Hamblin MR, Wen X (2023) Role of the skin microbiota and intestinal microbiome in rosacea. Front Microbiol 14:1108661. https://doi.org/10.3389/fmicb.2023.1108661CrossRefPubMedPubMedCentral

18.

Sáez-de-Ocariz M, Suárez-Gutiérrez M, Migaud M, Farrill-Romanillos O, P, Casanova JL, Segura-Mendez NH, Orozco-Covarrubias L, Espinosa-Padilla SE, Puel A, Blancas-Galicia L (2020) Rosacea as a striking feature in family members with a STAT1 gain-of-function mutation. J Eur Acad Dermatol Venereol 34(6):e265–e267. https://doi.org/10.1111/jdv.16241CrossRefPubMed

19.

Ahn CS, Huang WW (2018) Rosacea pathogenesis. Dermatol Clin 36(2):81–86. https://doi.org/10.1016/j.det.2017.11.001CrossRefPubMed

20.

Amir Ali A, Vender R, Vender R (2019) The role of IL-17 in papulopustular rosacea and future directions. J Cutan Med Surg 23(6):635–641. https://doi.org/10.1177/1203475419867611CrossRefPubMed

21.

Yamasaki K, Gallo RL (2009) The molecular pathology of rosacea. J Dermatol Sci 55(2):77–81. https://doi.org/10.1016/j.jdermsci.2009.04.007CrossRefPubMedPubMedCentral

22.

Zhou X, Su Y, Wu S, Wang H, Jiang R, Jiang X (2022) The temperature-sensitive receptors TRPV4 and TRPM8 have important roles in the pruritus of rosacea. J Dermatol Sci 108(2):68–76. https://doi.org/10.1016/j.jdermsci.2022.11.004CrossRefPubMed

23.

van Zuuren EJ, Fedorowicz Z (2015) Interventions for rosacea. JAMA 314(22):2403–2404. https://doi.org/10.1001/jama.2015.15287CrossRefPubMed

24.

Thiboutot DM, Fleischer AB, Del Rosso JQ, Graupe K (2008) Azelaic acid 15% gel once daily versus twice daily in papulopustular rosacea. J Drugs Dermatol 7(6):541–546. PMID: 18561584PubMed

25.

Koçak M, Yağli S, Vahapoğlu G, Ekşioğlu M (2002) Permethrin 5% cream versus metronidazole 0.75% gel for the treatment of papulopustular rosacea. A randomized double-blind placebo-controlled study. Dermatology. 205(3):265–270. https://doi.org/10.1159/000065849

26.

Noguera-Morel L, Gerlero P, Torrelo A, Hernández-Martín Á (2017) Ivermectin therapy for papulopustular rosacea and periorificial dermatitis in children: A series of 15 cases. J Am Acad Dermatol 76(3):567–570. https://doi.org/10.1016/j.jaad.2016.10.034CrossRefPubMed

27.

Schaller M, Gonser L, Belge K, Braunsdorf C, Nordin R, Scheu A, Borelli C (2017) Dual anti-inflammatory and anti-parasitic action of topical ivermectin 1% in papulopustular rosacea. J Eur Acad Dermatol Venereol 31(11):1907–1911. https://doi.org/10.1111/jdv.14437CrossRefPubMed

28.

Ollech A, Yousif R, Kruse L, Wagner A, Kenner-Bell B, Chamlin S, Yun D, Shen L, Vivar K, Reynolds M, Paller AS, Mancini AJ (2020) Topical calcineurin inhibitors for pediatric periorificial dermatitis. J Am Acad Dermatol 82(6):1409–1414. https://doi.org/10.1016/j.jaad.2020.01.064CrossRefPubMed

29.

Gonser LI, Gonser CE, Deuter C, Heister M, Zierhut M, Schaller M (2017) Systemic therapy of ocular and cutaneous rosacea in children. J Eur Acad Dermatol Venereol 31(10):1732–1738. https://doi.org/10.1111/jdv.14402CrossRefPubMed

30.

Schaller M, Kemény L, Havlickova B, Jackson JM, Ambroziak M, Lynde C, Gooderham M, Remenyik E, Del Rosso J, Weglowska J, Chavda R, Kerrouche N, Dirschka T, Johnson S (2020) A randomized phase 3b/4 study to evaluate concomitant use of topical ivermectin 1% cream and doxycycline 40-mg modified-release capsules, versus topical ivermectin 1% cream and placebo in the treatment of severe rosacea. J Am Acad Dermatol 82(2):336–343. https://doi.org/10.1016/j.jaad.2019.05.063CrossRefPubMed

31.

Kim SJ, Kim EH, Lee M, Baek JY, Lee JY, Shin JH, Lim SM, Kim MY, Jung I, Ahn JG, Kang CM, Kang JM (2022) Risk of dental discoloration and enamel dysplasia in children exposed to tetracycline and its derivatives. Yonsei Med J 63(12):1113–1120. https://doi.org/10.3349/ymj.2022.0388CrossRefPubMedPubMedCentral

32.

Levy M, Martin L, Bursztejn AC, Chiaverini C, Miquel J, Mahé E, Maruani A, Boralevi F; Groupe de Recherche de la Société Française de Dermatologie Pédiatrique (2020) Ivermectin safety in infants and children under 15 kg treated for scabies: a multicentric observational study. Br J Dermatol 182(4):1003–1006. https://doi.org/10.1111/bjd.18369CrossRef

33.

Cantarutti N, Claps A, Angelino G, Chessa L, Callea F, El Hachem M, Diociaiuti A, Finocchi A (2015) Multi-drugs resistant acne rosacea in a child affected by ataxia-telangiectasia: successful treatment with isotretinoin. Ital J Pediatr 41:23. https://doi.org/10.1186/s13052-015-0125-7CrossRefPubMedPubMedCentral

34.

Léoni S, Mesplié N, Aitali F, Chamaillard M, Boralevi F, Marques da Costa C, Taïeb A, Léauté-Labrèze C, Colin J, Mortemousque B (2011) Le métronidazole, alternative thérapeutique des rosacées oculaires et cutanées de l’enfant [Metronidazole: alternative treatment for ocular and cutaneous rosacea in the pediatric population]. J Fr Ophtalmol 34(10):703–710. https://doi.org/10.1016/j.jfo.2011.07.008CrossRefPubMed

35.

Hasbún ZC, Ogueta CI, Dossi CT, Wortsman X (2019) Idiopathic facial aseptic granuloma: updated review of diagnostic and therapeutic difficulties. Actas Dermosifiliogr (Engl Ed) 110(8):637–641. https://doi.org/10.1016/j.ad.2019.01.005CrossRef

36.

Blind E, Ropars N, Safa G (2018) Efficacité spectaculaire de l’ivermectine topique dans un cas de granulome facial aseptique idiopathique [Dramatic efficacy of topical ivermectin in idiopathic facial aseptic granuloma]. Ann Dermatol Venereol 145(12):792–794. https://doi.org/10.1016/j.annder.2018.07.019CrossRefPubMed

37.

Sanchez-Espino LF, Sibbald C (2022) Idiopathic facial aseptic granuloma: report of successful treatment with low-dose isotretinoin in a pediatric patient with trisomy 21. JAAD Case Rep 24:88–90. https://doi.org/10.1016/j.jdcr.2022.04.018CrossRefPubMedPubMedCentral

Title: Rosacea in children: a review
Authors: Anca Chiriac
Uwe Wollina
Publication date: 09-08-2023
Publisher: Springer Berlin Heidelberg
Keywords: Rosacea
Flush
Erythema
Ivermectin
Published in: European Journal of Pediatrics / Issue 10/2023
Print ISSN: 0340-6199
Electronic ISSN: 1432-1076
DOI: https://doi.org/10.1007/s00431-023-05083-0

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Rosacea in children: a review

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 10/2023

Population pharmacokinetics of oxcarbazepine active metabolite in Chinese children with epilepsy

Prognostic accuracy of Neonatal SOFA score versus SIRS criteria in preterm infants with late-onset sepsis

A randomized controlled trial of a home-based computerized executive function intervention for children with cerebral palsy

Serum perfluoroalkyl substances and growth and development in US adolescents: a nationally representative cross-sectional study

Neurodevelopmental outcomes of very preterm infants born following early foetal growth restriction with absent end-diastolic umbilical flow

The incidence of type 1 diabetes in children under 15 years of age is rising again—a nationwide study